DrugPatentWatch Database Preview
TRASICOR Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Trasicor, and what generic alternatives are available?
The generic ingredient in TRASICOR is oxprenolol hydrochloride. There is one drug master file entry for this compound. Additional details are available on the oxprenolol hydrochloride profile page.
Summary for TRASICOR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 47 |
| Patent Applications: | 402 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TRASICOR at DailyMed |
Medical Subject Heading (MeSH) Categories for TRASICOR
Synonyms for TRASICOR
| (+-)-BA 39089 |
| (1)-(3-(2-(Allyloxy)phenoxy)-2-hydroxypropyl)isopropylammonium chloride |
| 1-(2-(Allyloxy)phenoxy)-3-(isopropylamino)propan-2-ol hydrochloride |
| 1-(2-allyloxyphenoxy)-3-(isopropylamino)propan-2-ol hydrochloride |
| 1-(o-Allyloxyphenoxy)-3-isopropylamino-2-propanol hydrochloride |
| 1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol hydrochloride |
| 1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol;hydrochloride |
| 1-[(1-Methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-2-propanol hydrochloride |
| 1-[(1-methylethyl)amino]-3-{[2-(prop-2-en-1-yloxy)phenyl]oxy}propan-2-ol hydrochloride |
| 1-[2-(allyloxy)phenoxy]-3-(isopropylamino)propan-2-ol hydrochloride |
| 1-[2-(Allyloxy)phenoxy]-3-[isopropylamino]-2-propanol |
| 2-(o-Allyloxyphenoxy)-2-hydroxy-N-isopropyl-1-propylamine hydrochloride |
| 2-Propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-, hydrochloride |
| 2-Propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-, hydrochloride, (+-)- |
| 2-Propanol, 1-(o-(allyloxy)phenoxy)-3-(isopropylamino)-, hydrochloride, (+-)- |
| 2-Propanol, 1-(o-allyloxyphenoxy)-3-isopropylamino-, hydrochloride |
| 2-Propanol, 1-[(1-methylethyl)amino]- 3-[2-(2-propenyloxy)phenoxy]-, hydrochloride |
| 22972-97-0 |
| 3-[(methylethyl)amino]-1-(2-prop-2-enyloxyphenoxy)propan-2-ol, chloride |
| 6452-71-7 (Parent) |
| 6452-73-9 |
| 7348AE |
| AC1L2FOA |
| AC1Q3DNG |
| AK129836 |
| AKOS015994696 |
| AN-19335 |
| API0008993 |
| ARONIS24499 |
| AX8008165 |
| Ba 39089 |
| Ba-39089 |
| BBC/665 |
| C-18840 |
| C-39089-Ba |
| CAS-6452-73-9 |
| CCG-221057 |
| CCRIS 1097 |
| CHEMBL1200745 |
| Ciba 39089Ba |
| CTK8E6918 |
| D01806 |
| dl-1-(2-Allylphenoxy)-3-isopropylaminopropan-2-ol hydrochloride |
| dl-Alprenolol hydrochloride |
| Drospfta;ome |
| DSSTox_CID_1093 |
| DSSTox_GSID_21093 |
| DSSTox_RID_75936 |
| DTXSID5021093 |
| EINECS 229-260-5 |
| EINECS 245-358-0 |
| Evinrozit |
| Flecor |
| FT-0630349 |
| HMS1571C16 |
| KB-212502 |
| KS-1152 |
| laracor(hydrochloride) |
| LS-121645 |
| LS-7638 |
| MCULE-5603406124 |
| MFCD00058008 |
| MLS002154132 |
| MolPort-001-770-529 |
| NCGC00016675-01 |
| NCGC00179342-03 |
| Okuspurecol (TN) |
| OR207695 |
| Oxiprenolol hydrochloride |
| Oxprenolol HCl |
| Oxprenolol hydrochloride |
| Oxprenolol hydrochloride (JP17/USP) |
| Oxprenolol hydrochloride [USAN:JAN] |
| Oxprenolol Hydrochloride 1.0 mg/ml in Methanol (as free base) |
| Oxprenolol.HCl |
| OXPRENOLOLHYDROCHLORIDE |
| Ranidrox |
| Rixiprol |
| SBB058171 |
| SCHEMBL123517 |
| Secondafil |
| Slow-Trasicor |
| SMR001233439 |
| SR-01000841263 |
| SR-01000841263-2 |
| ST51015083 |
| Tox21_110556 |
| Tox21_110556_1 |
| TR-031398 |
| Vrachor |
| ZX-AS004866 |
US Patents and Regulatory Information for TRASICOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-001 | Dec 28, 1983 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-004 | Dec 28, 1983 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-002 | Dec 28, 1983 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-003 | Dec 28, 1983 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
Expired US Patents for TRASICOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-002 | Dec 28, 1983 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-004 | Dec 28, 1983 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-003 | Dec 28, 1983 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
see a sample report or, see our see our flat-rate plans
